Latest Articles
Research Challenges Menstrual Taboo, Promotes Inclusion - Mirage News
Research Challenges Menstrual Taboo, Promotes Inclusion Mirage News
Published: Nov. 27, 2025, 12:18 p.m.
Amazon has matched Best Buy's stunning AirPods offer — get AirPods 4 for their lowest-ever price - Mashable
Amazon has matched Best Buy's stunning AirPods offer — get AirPods 4 for their lowest-ever price Mashable
Published: Nov. 27, 2025, 11:55 a.m.
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells - News-Medical
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells News-Medical
Published: Nov. 27, 2025, 10:29 a.m.
Endometriosis Treatment Market at $1.55B, 7.7% CAGR - openPR.com
Endometriosis Treatment Market at $1.55B, 7.7% CAGR openPR.com
Published: Nov. 27, 2025, 10:19 a.m.
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships - Yahoo Finance
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships Yahoo Finance
Published: Nov. 27, 2025, 9:15 a.m.
'Cried for a week': the unseen emotional toll of 'excruciating' diagnosis - Western Advocate
'Cried for a week': the unseen emotional toll of 'excruciating' diagnosis Western Advocate
Published: Nov. 27, 2025, 8:39 a.m.
Amy Schumer Reveals She Gets ‘Misgendered a Lot’ Amid Reports of Marital Strain With Chris Fischer - Globe Magazine
Amy Schumer Reveals She Gets ‘Misgendered a Lot’ Amid Reports of Marital Strain With Chris Fischer Globe Magazine
Published: Nov. 26, 2025, 8:12 p.m.
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer - OncLive
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer OncLive
Published: Nov. 26, 2025, 7:03 p.m.
‘The Real Stuff’ Spotlights One Woman’s Fight for a Real Endometriosis Diagnosis After Years of Medical Dismissal - Dear Media
‘The Real Stuff’ Spotlights One Woman’s Fight for a Real Endometriosis Diagnosis After Years of Medical Dismissal Dear Media
Published: Nov. 26, 2025, 5:57 p.m.
NICE recommends treatment for primary advanced or recurrent endometrial cancer - Pf Media
NICE recommends treatment for primary advanced or recurrent endometrial cancer Pf Media
Published: Nov. 26, 2025, 4:10 p.m.
Link copied to clipboard!